The burden of COVID-19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic [0.03%]
糖尿病患者COVID-19住院负担：来自四年疫情的见解
Taís Mendes Camargo,Bianca Aparecida Siqueira,Luiz Felipe Azevedo Marques et al.
Taís Mendes Camargo et al.
Aims: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and in...
'Dancing with diabetes': Family coping strategies to promote psychological and behavioural adaptation in older children and adolescents with type 1 diabetes-A qualitative study [0.03%]
“与糖尿病共舞——家庭应对策略：代际视角下1型糖尿病儿童和青少年心理行为适应的质性研究
Huijing Zhang,Kun Li,Dan Luo et al.
Huijing Zhang et al.
Aims: To explore how families facilitate psychological and behavioural adaptation among older children and adolescents with T1D from the perspective of parents, children and families. ...
A qualitative study exploring and understanding the experiences and unmet needs of adults with type 2 diabetes and diabetes-related foot ulcers [0.03%]
一项定性研究：探索并了解2型糖尿病及糖尿病足溃疡患者的体验和未满足需求
Molly Caba,Jane Speight,Agnieszka Glab et al.
Molly Caba et al.
Aims: Diabetes-related foot ulcers (DFUs) are associated with depression, impaired health-related quality of life, an increased risk of cardiovascular disease and early mortality. To inform holistic care pathways, this qu...
Unravelling dialysis-related dysglycaemia: Longitudinal insights from continuous glucose monitoring [0.03%]
连续葡萄糖监测提供的纵向见解揭开了透析相关性糖尿病的症结
Hellena Hailu Habte-Asres,Ayodele Agbabiaka,Roha Rehan et al.
Hellena Hailu Habte-Asres et al.
Aim: To characterise CGM-derived glycaemic trajectories over 12months in people receiving maintenance haemodialysis, with a particular focus on hypoglycaemia burden and composite glycaemic risk. ...
Protective effects of 23-valent pneumococcal polysaccharide vaccination against mortality among elder patients with type 2 diabetes mellitus [0.03%]
23价肺炎球菌多糖疫苗对老年2型糖尿病患者死亡风险的保护作用分析
Xiaoling Peng,Shujun Gu,Jingchao Liu et al.
Xiaoling Peng et al.
Background: Older adults with type 2 diabetes mellitus are at elevated risk for severe pneumococcal disease, experiencing higher rates of complications and mortality. However, the evidence for the protective benefits of t...
Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes-related foot ulcer disease [0.03%]
专家意见指导2型糖尿病足溃疡患者的运动干预的开展与发展
Vicki L Johnson,Vicky Hall,Rachel Berrington et al.
Vicki L Johnson et al.
Objective: Engaging in exercise presents unique challenges for those with type 2 diabetes (T2D) and diabetes-related foot ulcer disease (DFUD). This brief report describes the development of practical considerations aimin...
Evaluation of a secondary care multidisciplinary clinic for adults with early-onset type 2 diabetes at high risk in Leicester, Leicestershire and Rutland [0.03%]
莱斯特、莱切斯特郡和鲁特兰高危成人2型糖尿病二级护理多学科诊所的评估
Jonathan Goldney,Malak Hamza,Priscilla Sarkar et al.
Jonathan Goldney et al.
Background: Clinical services for adults with early-onset type 2 diabetes (EOT2D) are in urgent need of improvement. Methods: We evalua...
Considerations for the clinical use of teplizumab in stage 2 Type 1 diabetes: A Consensus Statement from the British Society of Paediatric Endocrinology and Diabetes (BSPED) and the Association of British Clinical Diabetologists (ABCD) [0.03%]
关于抗T1D生物制剂teplizumab在2期1型糖尿病患者中应用的临床考量：英国儿童内分泌与糖尿病协会(BSPED)和英国临床糖尿病医师协会(ABCD)共识声明
Renuka P Dias,M Loredana Marcovecchio,Ruben H Willemsen et al.
Renuka P Dias et al.
Introduction: In 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of teplizumab (a monoclonal anti-CD3 antibody) to delay progression from Stage 2 to Stage 3 Type 1 diabetes in the UK....
Has the time come for a remission definition in type 1 diabetes? A functional perspective [0.03%]
从功能学角度看，是时候为1型糖尿病的缓解下个定义了吗？
Djordje S Popovic,Theocharis Koufakis
Djordje S Popovic